3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
155
Leukemia, Lymphocytic, Chronic, B-Cell
43
Lymphoma, Large B-Cell, Diffuse
26
Lymphoma
25
Lymphoma, Non-Hodgkin
23
Lymphoma, Mantle-Cell
23
Lymphoma, Follicular
23
Leukemia
22
Recurrence
21
Neoplasms, Plasma Cell
19
Myelodysplastic Syndromes
12
Lymphoma, B-Cell, Marginal Zone
12
Leukemia, Myeloid, Acute
12
Waldenstrom Macroglobulinemia
8
Smoldering Multiple Myeloma
8
Hodgkin Disease
8
Prostatic Neoplasms
7
Lymphoma, B-Cell
6
Lymphoma, T-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Hematologic Diseases
5
Sezary Syndrome
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Peripheral
4
Leukemia, Myelomonocytic, Chronic
4
Immunoblastic Lymphadenopathy
4
Anemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Polycythemia Vera
3
Lymphoma, T-Cell, Cutaneous
3
Interventions
ruxolitinib
4
ponatinib
4
nilotinib
4
Imatinib Mesylate
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
sonidegib
1
simtuzumab
1
pembrolizumab
1
ibrutinib
1
bosutinib
1
Zoledronic Acid
1
Denosumab
1
CPI-0610
1
BID protein, human
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Bone Marrow Diseases
×
Lenalidomide
×
Clear all
No trials found.